½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting



»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹KAT2B¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹KAT2B¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW10265
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º Íÿ¹KAT2B¶à¿Ë¡¿¹Ìå 

Ó¢ÎÄÃû³Æ£º Anti-KAT2B rabbit polyclonal antibody

±ð     Ãû£º CAF; PCAF; P/CAF

Ïà¹ØÀà±ð£º Ò»¿¹

´¢     ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

¿¹     Ô­£º KAT2B

ËÞ     Ö÷£º Rabbit

·´Ó¦ÖÖÊô£º Human Mouse Rat

±ê ¼Ç Î Unconjugate

¿Ë¡ÀàÐÍ£º Unconjugate

¼¼Êõ¹æ¸ñ

Background:

CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP.

Applications:

WB, IHC

Name of antibody:

KAT2B

Immunogen:

Synthesized peptide derived from human P300/CBP.

Full name:

K(lysine) acetyltransferase 2B

Synonyms£º

CAF; PCAF; P/CAF

SwissProt:

Q92831

IHC positive control:

Human breast carcinoma tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

93 kDa

WB Positive control:

COLO205 cells lysate

WB Recommended dilution:

500-3000









¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿